• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 10-Q filed by Reeds Inc.

    11/14/24 4:00:47 PM ET
    $REED
    Get the next $REED alert in real time by email
    false Q3 --12-31 0001140215 0001140215 2024-01-01 2024-09-30 0001140215 2024-11-13 0001140215 2024-09-30 0001140215 2023-12-31 0001140215 us-gaap:RelatedPartyMember 2024-09-30 0001140215 us-gaap:RelatedPartyMember 2023-12-31 0001140215 2024-07-01 2024-09-30 0001140215 2023-07-01 2023-09-30 0001140215 2023-01-01 2023-09-30 0001140215 us-gaap:CommonStockMember 2024-06-30 0001140215 us-gaap:PreferredStockMember 2024-06-30 0001140215 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001140215 us-gaap:RetainedEarningsMember 2024-06-30 0001140215 2024-06-30 0001140215 us-gaap:CommonStockMember 2023-12-31 0001140215 us-gaap:PreferredStockMember 2023-12-31 0001140215 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001140215 us-gaap:RetainedEarningsMember 2023-12-31 0001140215 us-gaap:CommonStockMember 2023-06-30 0001140215 us-gaap:PreferredStockMember 2023-06-30 0001140215 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001140215 us-gaap:RetainedEarningsMember 2023-06-30 0001140215 2023-06-30 0001140215 us-gaap:CommonStockMember 2022-12-31 0001140215 us-gaap:PreferredStockMember 2022-12-31 0001140215 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001140215 us-gaap:RetainedEarningsMember 2022-12-31 0001140215 2022-12-31 0001140215 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001140215 us-gaap:PreferredStockMember 2024-07-01 2024-09-30 0001140215 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001140215 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001140215 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001140215 us-gaap:PreferredStockMember 2024-01-01 2024-09-30 0001140215 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-09-30 0001140215 us-gaap:RetainedEarningsMember 2024-01-01 2024-09-30 0001140215 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001140215 us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001140215 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001140215 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001140215 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001140215 us-gaap:PreferredStockMember 2023-01-01 2023-09-30 0001140215 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0001140215 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0001140215 us-gaap:CommonStockMember 2024-09-30 0001140215 us-gaap:PreferredStockMember 2024-09-30 0001140215 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001140215 us-gaap:RetainedEarningsMember 2024-09-30 0001140215 us-gaap:CommonStockMember 2023-09-30 0001140215 us-gaap:PreferredStockMember 2023-09-30 0001140215 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001140215 us-gaap:RetainedEarningsMember 2023-09-30 0001140215 2023-09-30 0001140215 us-gaap:ShippingAndHandlingMember 2024-07-01 2024-09-30 0001140215 us-gaap:ShippingAndHandlingMember 2023-07-01 2023-09-30 0001140215 us-gaap:ShippingAndHandlingMember 2024-01-01 2024-09-30 0001140215 us-gaap:ShippingAndHandlingMember 2023-01-01 2023-09-30 0001140215 REED:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-07-01 2024-09-30 0001140215 REED:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-07-01 2024-09-30 0001140215 REED:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-09-30 0001140215 REED:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-09-30 0001140215 REED:CustomerThreeMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-09-30 0001140215 REED:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-07-01 2023-09-30 0001140215 REED:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-07-01 2023-09-30 0001140215 REED:CustomerThreeMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-07-01 2023-09-30 0001140215 REED:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-09-30 0001140215 REED:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-09-30 0001140215 REED:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001140215 REED:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001140215 REED:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001140215 REED:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001140215 REED:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001140215 REED:VendorOneMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-09-30 0001140215 REED:VendorTwoMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-09-30 0001140215 REED:VendorOneMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-09-30 0001140215 REED:VendorOneMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001140215 REED:VendorOneMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001140215 REED:VendorTwoMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001140215 2023-01-01 2023-12-31 0001140215 us-gaap:WarrantMember 2024-01-01 2024-09-30 0001140215 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001140215 us-gaap:StockOptionMember 2024-01-01 2024-09-30 0001140215 us-gaap:StockOptionMember 2023-01-01 2023-09-30 0001140215 us-gaap:ConvertibleNotesPayableMember 2024-01-01 2024-09-30 0001140215 us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-09-30 0001140215 REED:CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember 2024-01-01 2024-09-30 0001140215 REED:CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember 2023-01-01 2023-09-30 0001140215 REED:RightOfUseAssetsUnderOperatingLeasesMember 2024-09-30 0001140215 REED:RightOfUseAssetsUnderOperatingLeasesMember 2023-12-31 0001140215 REED:ComputerHardwareAndSoftwareMember 2024-09-30 0001140215 REED:ComputerHardwareAndSoftwareMember 2023-12-31 0001140215 us-gaap:MachineryAndEquipmentMember 2024-09-30 0001140215 us-gaap:MachineryAndEquipmentMember 2023-12-31 0001140215 us-gaap:ConstructionInProgressMember 2024-09-30 0001140215 us-gaap:ConstructionInProgressMember 2023-12-31 0001140215 REED:AlternaCapitalSolutionsMember 2024-09-30 0001140215 REED:AlternaCapitalSolutionsMember 2023-12-31 0001140215 REED:AlternaCapitalSolutionsMember 2022-03-01 2022-03-31 0001140215 REED:AlternaCapitalSolutionsMember 2022-03-31 0001140215 REED:WhiteboxAnotherSecuredLenderMember 2022-03-31 0001140215 REED:AlternaCapitalSolutionsMember 2024-01-01 2024-09-30 0001140215 REED:NormanESnyderMember 2024-07-26 2024-07-26 0001140215 REED:NotesPayableAMember 2024-09-30 0001140215 REED:NotesPayableAMember 2023-12-31 0001140215 REED:NotesPayableBMember 2024-09-30 0001140215 REED:NotesPayableBMember 2023-12-31 0001140215 REED:SecuredConvertibleNotesPayableMember 2024-09-30 0001140215 REED:SecuredConvertibleNotesPayableMember 2023-12-31 0001140215 REED:NotesPayableBMember 2024-08-01 2024-08-01 0001140215 REED:NotePurchaseAgreementMember 2022-05-31 0001140215 REED:NotePurchaseAgreementMember 2022-05-01 2022-05-31 0001140215 2022-08-01 2022-08-01 0001140215 REED:NotePurchaseAgreementMember 2023-01-01 2023-10-31 0001140215 REED:WhiteboxAdvisorsLLCMember us-gaap:ConvertibleNotesPayableMember 2023-11-01 2023-11-30 0001140215 REED:NotePurchaseAgreementMember 2024-01-01 2024-12-31 0001140215 REED:NotesPayableAMember 2024-08-01 0001140215 REED:NotesPayableBMember 2024-08-01 0001140215 REED:WhiteboxAdvisorsLLCMember us-gaap:ConvertibleNotesPayableMember 2023-12-31 0001140215 REED:WhiteboxAdvisorsLLCMember us-gaap:ConvertibleNotesPayableMember 2024-01-01 2024-09-30 0001140215 REED:WhiteboxAdvisorsLLCMember us-gaap:ConvertibleNotesPayableMember 2024-09-30 0001140215 2024-05-10 0001140215 2024-05-10 2024-05-10 0001140215 REED:SimpleAgreementsForFutureEquityInvestmentsMember REED:StockholdersMember 2024-01-01 2024-03-31 0001140215 REED:SimpleAgreementsForFutureEquityInvestmentsMember REED:StockholdersMember 2024-03-31 0001140215 REED:SimpleAgreementsForFutureEquityInvestmentsMember 2024-06-30 0001140215 REED:SimpleAgreementsForFutureEquityInvestmentsMember 2024-01-01 2024-09-30 0001140215 REED:SecuritiesPurchaseAgreementMember 2024-09-09 2024-09-09 0001140215 REED:SecuritiesPurchaseAgreementMember REED:DAndDSourceOfLifeHoldingLtdMember 2024-09-09 2024-09-09 0001140215 REED:SimpleAgreementsForFutureEquityInvestmentsMember 2024-07-01 2024-09-30 0001140215 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-09-30 0001140215 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0001140215 us-gaap:EmployeeStockOptionMember 2024-09-30 0001140215 us-gaap:WarrantMember 2023-12-31 0001140215 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001140215 us-gaap:WarrantMember 2024-01-01 2024-09-30 0001140215 us-gaap:WarrantMember 2024-09-30 0001140215 REED:SecuritiesPurchaseAgreementMember 2024-09-30 0001140215 REED:ChristopherJReedMember REED:CaliforniaCustomBeverageLLCMember 2018-12-31 0001140215 REED:CaliforniaCustomBeverageLLCMember 2024-09-30 0001140215 REED:CaliforniaCustomBeverageLLCMember 2023-12-31 0001140215 srt:MaximumMember 2023-12-31 0001140215 REED:ChrisReedMember REED:CaliforniaCustomBeverageLLCMember 2018-12-31 0001140215 REED:ChrisReedMember REED:CaliforniaCustomBeverageLLCMember 2024-09-30 0001140215 REED:ChrisReedMember REED:CaliforniaCustomBeverageLLCMember us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001140215 REED:ChrisReedMember REED:CaliforniaCustomBeverageLLCMember 2024-01-01 2024-09-30 0001140215 us-gaap:SubsequentEventMember 2024-11-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure REED:Integer

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 10-Q

     

    ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the quarterly period ended September 30, 2024

     

    ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934

     

    For the transition period from _______ to _______

     

    Commission file number: 001-32501

     

    REED’S, INC.

    (Exact name of registrant as specified in its charter)

     

    Delaware   35-2177773
    (State of
    incorporation)
      (I.R.S. Employer
    Identification No.)

     

    201 Merritt 7, Norwalk, CT. 06851

    (Address of principal executive offices) (Zip Code)

     

    (800) 997-3337

    (Registrant’s telephone number, including area code)

     

    Securities registered pursuant to Section 12(b) of the Act: None

     

    Title of Each Class   Trading Symbol   Names of each exchange on which registered
             

     

    Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: There were a total of 4,187,291 shares of Common Stock outstanding as of May 10, 2024.

     

    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

     

    Yes ☒ No ☐

     

    Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:

     

    Large Accelerated Filer ☐ Accelerated Filer ☐ Non-Accelerated Filer ☒
    Smaller Reporting Company ☒ Emerging Growth Company ☐  

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

    Indicate by check mark whether the issuer is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

     

    There are 8,187,291 shares outstanding as of November 13, 2024.

     

     

     

     

     

     

    TABLE OF CONTENTS

     

    PART I - FINANCIAL INFORMATION F-1
       
    Item 1. Condensed Financial Statements F-1
       
    Condensed Balance Sheets - September 30, 2024 (Unaudited) and December 31, 2023 F-1
       
    Condensed Statements of Operations for the three and nine months ended September 30, 2024 and 2023 (Unaudited) F-2
       
    Condensed Statements of Changes in Stockholders’ Deficit for the three and nine months ended September 30, 2024 and 2023 (Unaudited) F-3
       
    Condensed Statements of Cash Flows for the nine months ended September 30, 2024 and 2023 (Unaudited) F-4
       
    Notes to Condensed Financial Statements three and nine months ended September 30, 2024 and 2023 (Unaudited) F-5
       
    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 1
       
    Item 3. Quantitative and Qualitative Disclosures About Market Risk 11
       
    Item 4. Controls and Procedures 11
       
    PART II – OTHER INFORMATION 11
       
    Item 1. Legal Proceedings 11
       
    Item 1A. Risk Factors 11
       
    Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 11
       
    Item 3. Defaults Upon Senior Securities 11
       
    Item 4. Mine Safety Disclosures 11
       
    Item 5. Other Information 12
       
    Item 6. Exhibits 12

     

    i
     

     

    CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS AND INFORMATION

     

    This report contains statements reflecting our views about our future performance that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (Reform Act). Statements that constitute forward-looking statements within the meaning of the Reform Act are generally identified through the inclusion of words such as “aim,” “anticipate,” “believe,” “drive,” “estimate,” “expect,” “expressed confidence,” “forecast,” “future,” “goal,” “guidance,” “intend,” “may,” “objective,” “outlook,” “plan,” “position,” “potential,” “project,” “seek,” “should,” “strategy,” “target,” “will” or similar statements or variations of such words and other similar expressions. All statements addressing our future operating performance, and statements addressing events and developments that we expect or anticipate will occur in the future, are forward-looking statements within the meaning of the Reform Act. These forward-looking statements are based on currently available information, operating plans and projections about future events and trends. They inherently involve risks and uncertainties that could cause actual results to differ materially from those predicted in any such forward-looking statement. These risks and uncertainties include, but are not limited to, those described in “Part I, Item 1A. Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (“2023 Form 10-K”) as updated by “Part II, Item 1A” of this report should be considered when evaluating our trends and future results. Investors are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. The discussion of risks in this report is by no means all-inclusive but is designed to highlight what we believe are important factors to consider when evaluating our future performance.

     

    ii
     

     

    Part I – FINANCIAL INFORMATION

     

    Item 1. Financial Statements

     

    REED’S, INC.

    CONDENSED BALANCE SHEETS

    (Amounts in thousands, except share amounts)

     

       September 30,
    2024
       December 31,
    2023
     
        (Unaudited)      
    ASSETS          
    Current assets:          
    Cash  $306   $603 
    Accounts receivable, net of allowance of $577 and $860, respectively   2,770    3,571 
    Inventory   9,251    11,300 
    Receivable from former related party   259    259 
    Prepaid expenses and other current assets   1,476    2,028 
    Total current assets   14,062    17,761 
               
    Property and equipment, net of accumulated depreciation of $1,277 and $1,068, respectively   335    493 
    Intangible assets   636    629 
    Total assets  $15,033   $18,883 
               
    LIABILITIES AND STOCKHOLDERS’ DEFICIT          
    Current liabilities:          
    Accounts payable  $8,313   $9,133 
    Accrued expenses   1,274    1,096 
    Revolving line of credit, net of capitalized financing costs of $81 and $201, respectively   5,390    9,758 
    Payable to former related party   211    259 
    Current portion of convertible notes payable, net of debt discount of $459 and $572, respectively   21,751    6,737 
    Current portion of lease liabilities   47    207 
    Total current liabilities   36,986    27,190 
               
    Convertible note payable, net of debt discount of $0 and $148, respectively, less current portion   -    10,874 
    Total liabilities   36,986    38,064 
               
    Stockholders’ deficit:          
    Series A Convertible Preferred stock, $10 par value, 500,000 shares authorized, 9,411 shares issued and outstanding   94    94 
    Common stock, $.0001 par value, 180,000,000 shares authorized; 8,187,291 and 4,187,291 shares issued and outstanding, respectively   1    - 
    Additional paid in capital   125,719    119,452 
    Accumulated deficit   (147,767)   (138,727)
    Total stockholders’ deficit   (21,953)   (19,181)
    Total liabilities and stockholders’ deficit  $15,033   $18,883 

     

    The accompanying notes are an integral part of these condensed financial statements.

     

    F-1
     

     

    REED’S, INC.

    CONDENSED STATEMENTS OF OPERATIONS

    For the Three and Nine Months Ended September 30, 2024 and 2023

    (Unaudited)

    (Amounts in thousands, except share and per share amounts)

     

       2024   2023   2024   2023 
      

    Three Months Ended

    September 30,

      

    Nine Months Ended

    September 30,

     
       2024   2023   2024   2023 
    Net Sales  $6,752   $11,856   $28,221   $33,018 
    Cost of goods sold   5,537    7,823    19,762    23,778 
    Gross profit   1,215    4,033    8,459    9,240 
                         
    Operating expenses:                    
    Delivery and handling expense   1,279    1,908    4,204    5,714 
    Selling and marketing expense   1,283    861    3,473    3,567 
    General and administrative expense   1,791    1,407    5,239    4,427 
    Total operating expenses   4,353    4,176    12,916    13,708 
                         
    Loss from operations   (3,138)   (143)   (4,457)   (4,468)
                         
    Interest expense   (2,405)   (1,293)   (4,578)   (4,459)
    Change in fair value of SAFE investments   1,393    -    -    - 
                         
    Net loss   (4,150)   (1,436)   (9,035)   (8,927)
                         
    Dividends on Series A Convertible Preferred Stock   -    -    (5)   (5)
                         
    Net Loss Attributable to Common Stockholders  $(4,150)  $(1,436)  $(9,040)  $(8,932)
                         
    Loss per share – basic and diluted  $(0.82)  $(0.34)  $(2.02)  $(2.69)
                         
    Weighted average number of shares outstanding – basic and diluted   5,066,412    4,169,131    4,483,587    3,322,959 

     

    The accompanying notes are an integral part of these condensed financial statements.

     

    F-2
     

     

    REED’S, INC.

    CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

    For the Three and Nine Months Ended September 30, 2024 and 2023

    (Unaudited)

    (Amounts in thousands except share amounts)

     

       Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
       Common Stock   Preferred Stock   Additional Paid In   Accumulated   Total Stockholders’ 
       Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
    Balance, June 30, 2024   4,187,291   $    -    9,411   $94   $119,674   $(143,617)  $(23,849)
    Fair value of vested options                       46         46 
    Common shares issued for cash   1,268,795                   1,903         1,903 
    Common shares issued upon conversion of SAFE agreement   2,731,205    

    1

                  4,096         4,097 
    Net loss             -    -    -    (4,150)   (4,150)
    Balance, September 30, 2024   8,187,291   $

    1

        9,411   $94   $125,719   $(147,767)  $(21,953)

     

       Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
       Common Stock   Preferred Stock   Additional Paid In   Accumulated   Total Stockholders’ 
       Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
    Balance, December 31, 2023   4,187,291   $   -    9,411   $94   $119,452   $(138,727)  $(19,181)
    Fair value of vested options                       268         268 
    Dividends on Series A Convertible Preferred Stock   -    -         -         (5)   (5)
    Common shares issued for cash   

    1,268,795

                       

    1,903

             

    1,903

     

    Common shares issued upon conversion of SAFE agreement

       2,731,205    

    1

             -    4,096         4,097 
    Net loss             -    -    -    (9,035)   (9,035)
    Balance, September 30, 2024   8,187,291   $

    1

        9,411   $94   $125,719   $(147,767)  $(21,953)

     

       Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
       Common Stock   Preferred Stock   Additional Paid In   Accumulated   Total Stockholders’ 
       Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
    Balance, June 30, 2023   4,169,131   $   -    9,411   $94   $119,138   $(130,695)  $(11,463)
    Fair value of vested options   -    -              139         139 
    Net loss   -    -    -    -    -    (1,436)   (1,436)
    Balance, September 30, 2023   4,169,131   $-    9,411   $94   $119,277   $(132,131)  $(12,760)

     

       Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
       Common Stock   Preferred Stock   Additional Paid In   Accumulated   Total Stockholders’ 
       Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
    Balance, December 31, 2022   2,519,485   $     -    9,411   $94   $114,635   $(123,199)  $(8,470)
    Balance   2,519,485   $     -    9,411   $94   $114,635   $(123,199)  $(8,470)
    Fair value of vested options                       351         351 
    Fair value of vested restricted shares granted to officers   750                   3         3 
    Repurchase of common stock   (274)                  (1)        (1)
    Common shares issued for financing costs   82,438                   273         273 
    Dividends on Series A Convertible Preferred Stock   -    -         -         (5)   (5)
    Common shares issued for cash, net of offering costs   1,566,732    -              4,016         4,016 
    Net loss             -    -    -    (8,927)   (8,927)
    Balance, September 30, 2023   4,169,131   $-    9,411   $94   $119,277   $(132,131)  $(12,760)
    Balance   4,169,131   $-    9,411   $94   $119,277   $(132,131)  $(12,760)

     

    The accompanying notes are an integral part of these condensed financial statements.

     

    F-3
     

     

    REED’S, INC.

    CONDENSED STATEMENTS OF CASH FLOWS

    For the Nine Months Ended September 30, 2024 and 2023

    (Unaudited)

    (Amounts in thousands)

     

       September 30,
    2024
       September 30,
    2023
     
    Cash flows from operating activities:          
    Net loss  $(9,035)  $(8,927)
    Adjustments to reconcile net loss to net cash used in operating activities:          
    Depreciation   88    112 
    Loss on disposal of property and equipment        9 
    Amortization of debt discount   568    958 
    Fair value of vested options   268    351 
    Fair value of vested restricted shares granted to officers   

    -

        3 
    Product quality hold write-down   (29)     
    Change in allowance for doubtful accounts   (282)   262 
    Inventory write-downs   (825)   (205)
    Accrued interest   3,141    2,483 
    Changes in operating assets and liabilities:          
    Accounts receivable   1,084    142 
    Inventory   2,903    417 
    Prepaid expenses and other assets   (449)   450 
    Decrease in right of use assets   121    102 
    Accounts payable   180   (738)
    Accrued dividend   -    (5)
    Accrued expenses   173    639 
    Lease liabilities   (160)   (137)
    Net cash used in operating activities   (2,254)   (4,084)
    Cash flows from investing activities:          
    Trademark costs   (7)   (1)
    Purchase of property and equipment   (51)   (84)
    Sale of property and equipment   -    68 
    Net cash used in investing activities   (58)   (17)
    Cash flows from financing activities:          
    Proceeds from line of credit   24,878    32,686 
    Payments on line of credit   (29,367)   (34,085)
    Proceeds from convertible note payable, net of expenses   -    3,797 
    Payment of accrued interest on convertible note payable   (513)   (268)
    Proceeds from sale of common stock   1,903    4,016 
    Proceeds from convertible notes   1,400    - 
    Proceeds from issuance of SAFE agreement   

    4,097

        (1)
    Payment of cash recorded as debt discount   (335)   - 
    Amounts from former related party, net   (48)   (1,573)
    Net cash provided by financing activities   2,015    4,572 
               
    Net decrease in cash   (297)   471 
    Cash at beginning of period   603    533 
    Cash at end of period  $306   $1,004 
               
    Supplemental disclosures of cash flow information:          
    Cash paid for interest  $238   $548 
    Non-cash investing and financing activities:          
    Dividends on Series A Convertible Preferred Stock  $5   $5 
    Reclass of prepaid expenses and accounts payable   1,000      

     

    The accompanying notes are an integral part of these condensed financial statements.

     

    F-4
     

     

    REED’S, INC.

    NOTES TO CONDENSED FINANCIAL STATEMENTS

    Three and Nine Months Ended September 30, 2024 and 2023 (Unaudited)

    (In thousands, except share and per share amounts)

     

    1. Summary of Significant Accounting Policies

     

    Basis of Presentation

     

    The accompanying condensed financial statements of Reed’s, Inc. (the “Company”, “we”, “us”, or “our”), have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. We believe that the disclosures contained in these condensed financial statements are adequate to make the information presented herein not misleading. These condensed financial statements should be read in conjunction with the financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on April 1, 2024. The accompanying condensed financial statements are unaudited, but in the opinion of management, contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company’s financial position as of September 30, 2024, and the results of its operations and its cash flows for the nine months ended September 30, 2024 and 2023. The balance sheet as of December 31, 2023 is derived from the Company’s audited financial statements.

     

    The results of operations for the nine months ended September 30, 2024, are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2024.

     

    Going Concern

     

    The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, for the nine months ended September 30, 2024, the Company recorded a net loss of $9,035, and utilized $2,254 of cash in operations and at September 30, 2024, had a working capital deficiency of $22,923 and a stockholders’ deficit of $21,953. As of September 30, 2024, the Company borrowed $5,471 on its line of credit and owed $22,210 on its Notes (See Note 5 and Note 6 for further detail). These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. The financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s independent registered public accounting firm, in its report on the Company’s consolidated financial statements for the year ended December 31, 2023, has also expressed substantial doubt about the Company’s ability to continue as a going concern.

     

    As of September 30, 2024, we had a cash balance of $306, no availability under our line of credit and $7,529 of additional borrowing capacity from the credit facility assuming there is availability under the terms.

     

    Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. To alleviate these conditions, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic partners or through obtaining credit from financial institutions. The Company is continuing to discuss restructuring of debt with existing lenders and is exploring new financing opportunities to address the line of credit which comes due in March 2025 (see Note 5) and the portion of the debt under the Notes which comes due on December 15, 2024 (see Note 6). As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.

     

    F-5
     

     

    We have also taken decisive action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating improved vendor contracts and restructuring our selling prices.

     

    Recent Trends - Market Conditions

     

    Although the U.S. economy continued to grow throughout 2023 and into Q3 2024, the higher inflation, the actions by the Federal Reserve to address inflation, and rising energy prices create uncertainty about the future economic environment which will continue to evolve and may impact our business in future periods. We have experienced supply chain challenges, including increased lead times, as well as inflation of raw materials, logistics and labor costs due to availability constraints and high demand. Although we regularly monitor companies in our supply chain, and use alternative suppliers when necessary and available, supply chain constraints could cause a disruption in our ability to obtain raw materials required to manufacture our products and adversely affect our operations.

     

    During the three months ending September 30, 2024, the Company continued to experience moderation from the elevated freight costs experienced in 2023. The average cost of shipping and handling for the three months ended September 30, 2024, was $2.99 as compared to $2.98 in the three months ended September 30, 2023. During the nine months ended September 30, 2024, the average cost of shipping and handling was $2.66 per case, as compared to $3.17 per case for the nine months ended September 30, 2023. Although the Company has experienced decreases in freight costs over the last four quarters, in the Company’s opinion there remains a volatile environment and the Company will continue to monitor pricing and availability in transportation. Mitigation plans have been implemented to manage this risk. The Company has been negatively impacted by supply chain challenges affecting our ability to benefit from strong demand for, and increased sales of our product. The disruption caused by labor shortages, significant raw material cost inflation, logistics issues and increased freight costs, and ongoing port congestion, resulted in suppressed margins. The Company has experienced moderation in inflation and anticipates this continuing throughout 2024.

     

    Use of Estimates

     

    The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for credit loss reserves for accounts receivable, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, assumptions in determining the fair value of our SAFE investments and assumptions used in the determination of the Company’s liquidity.

     

    Revenue Recognition

     

    The Company recognizes revenue in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers (“ASC 606”). Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon shipment from our facilities. The Company’s performance obligations are satisfied at that time. The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfilment activity rather than a promised service to the customer. All of the Company’s products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them.

     

    The Company does not allow for returns, except for damaged products when damage occurred pre-fulfilment. Damaged product returns have historically been insignificant. Because of this, the stand-alone nature of our products, and our assessment of performance obligations and transaction pricing for our sales contracts, we do not currently maintain a contract asset or liability balance for obligations. We assess our contracts and the reasonableness of our conclusions on a quarterly basis.

     

    F-6
     

     

    Loss per Common Share

     

    Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year, excluding shares of unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings (loss) per share is computed by dividing the net income applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from computation when their effect is antidilutive.

     

    For the periods ended September 30, 2024 and 2023, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following:

     

    Schedule of Potentially Dilutive Securities

       September 30,
    2024
       September 30,
    2023
     
    Warrants   549,292    549,292 
    Options   128,309    145,012 
    Convertible note payable   1,844,829    1,475,725 
    Common stock equivalent of Series A Convertible Preferred stock   753    753 
    Total   2,523,183    2,170,782 

     

    Stock Compensation Expense

     

    The Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, Compensation-Stock Compensation whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expenses for non-employees is in the same period and manner as if the Company had paid cash for the services. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.

     

    The fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.

     

    Advertising Costs

     

    Advertising costs are expensed as incurred and are included in selling and marketing expense. Advertising costs for the three months ended September 30, 2024, and 2023, aggregated $8 and $22, respectively. Advertising costs for the nine months ended September 30, 2024, and 2023, aggregated $38 and $82, respectively.

     

    Concentrations

     

    Net sales. During the three months ended September 30, 2024, two customers accounted for 18% and 15% of gross billing, respectively, and during the nine months ended September 30, 2024, three customers accounted for 18%, 15%, and 11% of gross billing, respectively. During the three months ended September 30, 2023, three customers accounted for 22%, 14%, and 12% of gross billing, respectively, and during the nine months ended September 30, 2023, two customers accounted for 19% and 13% of gross billing, respectively. No other customers exceeded 10% of sales in either period.

     

    F-7
     

     

    Accounts receivable. As of September 30, 2024, the Company had accounts receivable from two customers which comprised 32% and 13% of its gross accounts receivable, respectively. As of December 31, 2023, the Company had accounts receivable from three customers which comprised 24%, 15% and 11% of its gross accounts receivable, respectively. No other customers exceeded 10% of gross accounts receivable in either period.

     

    The Company utilizes co-packers to produce 100% of its products. During the nine months ended September 30, 2024 and the year ended December 31, 2023, the Company utilized nine separate co-packers for most its production and bottling of beverage products in the United States. The Company has long-standing relationships with two different co-packers, and a third co-packing agreement with California Custom Beverage LLC (“CCB”), a former related party (see Note 11). Although there are other packers, a change in co-packers may cause a delay in the production process, which could ultimately affect operating results.

     

    Purchases from vendors. During the nine months ended September 30, 2024, the Company’s two largest vendors accounted for approximately 11% and 10% of all purchases. During the nine months ended September 30, 2023, the Company’s largest vendor accounted for approximately 9% of all purchases. No other vendors exceeded 10% of all purchases in either period.

     

    Accounts payable. As of September 30, 2024, no vendor accounted for more than 10% of total accounts payable. As of December 31, 2023, two vendors accounted for 10% and 10% of total accounts payable, respectively. No other vendors exceeded 10% of accounts payable in either period.

     

    Fair Value of Financial Instruments

     

    The Company uses various inputs in determining the fair value of its financial assets and liabilities and measures these assets on a recurring basis. Financial assets recorded at fair value are categorized by the level of subjectivity associated with the inputs used to measure their fair value. ASC 820 defines the following levels of subjectivity associated with the inputs:

     

    Level 1—Quoted prices in active markets for identical assets or liabilities.

    Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.

    Level 3—Unobservable inputs based on the Company’s assumptions.

     

    The carrying amounts of financial assets and liabilities, such as cash and cash equivalents, accounts receivable, short-term bank loans, accounts payable, notes payable and other payables, approximate their fair values because of the short maturity of these instruments. The carrying values of capital lease obligations and long-term financing obligations approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.

     

    The fair value of our liability under our SAFE investments were determined using level 3 inputs. (Note 8)

     

    Reclassifications

     

    Certain prior year amounts have been reclassified for consistency with the current period presentation. Collection from customers amounting to $1,217 that was previously presented as a deduction from prepaid expenses at December 31, 2023 have been reclassed as an offset against accounts receivable. This reclassification had no effect on the reported results of operations or cash flows.

     

    Recent Accounting Pronouncements

     

    In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosure, which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expense categories that are regularly provided to the chief operating decision maker and included in each reported measure of a segment’s profit or loss. The update also requires all annual disclosures about a reportable segment’s profit or loss and assets to be provided in interim periods and for entities with a single reportable segment to provide all the disclosures required by ASC 280, Segment Reporting, including the significant segment expense disclosures. This standard became effective for the Company on January 1, 2024. to The adoption of 2023-7 did not have a material impact on the Company’s results of operations, financial position or cash flows.

     

    F-8
     

      

    Other recent accounting pronouncements and guidance issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

     

    2. Inventory

     

    Inventory is valued at the lower of cost (first-in, first-out) or net realizable value, net of write downs, and is comprised of the following (in thousands):

     

    Schedule of Inventory

       September 30,
    2024
       December 31,
    2023
     
    Raw materials and packaging  $6,143   $6,445 
    Finished products   3,108    4,855 
    Total  $9,251   $11,300 

     

    3. Property and Equipment

     

    Property and equipment are comprised of the following (in thousands):

     

    Schedule of Property and Equipment

       September 30,
    2024
       December 31,
    2023
     
    Right-of-use assets under operating leases  $724   $724 
    Computer hardware and software   400    400 
    Machinery and equipment   352    352 
    Construction in progress   136    85 
    Total cost   1,612    1,561 
    Accumulated depreciation and amortization   (1,277)   (1,068)
    Net value  $335   $493 

     

    Depreciation expense for the nine months ended September 30, 2024 and 2023 was $88 and $112, respectively, and amortization of right-of-use assets for the nine months ended September 30, 2024 and 2023 was $121 and $102, respectively.

     

    4. Intangible Assets

     

    Intangible assets consist of the following (in thousands):

     

    Summary of Intangible Assets

       September 30,
    2024
       December 31,
    2023
     
    Brand names  $576   $576 
    Trademarks   60    53 
    Total  $636   $629 

     

    F-9
     

     

    5. Line of Credit

     

    The Company’s credit facility consisted of the following (in thousands):

    Schedule of Amount Outstanding Under Credit Facilities

       September 30,
    2024
       December 31,
    2023
     
    Line of credit – Alterna Capital Solutions  $5,471   $9,959 
    Less: capitalized financing costs   (81)   (201)
    Total  $5,390   $9,758 

     

    In March, 2022, the Company entered into a financing agreement for a line of credit with Alterna Capital Solutions (“ACS”). The ACS line of credit is for a term of 3 years, provides for borrowings of up to $13,000, and is secured by eligible accounts receivable and inventory, and are subject to a collateral sharing agreement with Whitebox, another secured lender (see Note 6). An over advance rider provides for up to $500 of additional borrowing above the collateralized base (the “Over Advance”) up to a total borrowing of $13,500. As of September 30, 2024, there was no remaining availability under the line of credit, and $7,529 of borrowing capacity available.

     

    Borrowings based on receivables bears an interest of prime plus 4.75% but not less than 8.0% (13.25% at September 30, 2024 and 13.25% at December 31, 2023). Borrowings based on inventory bears an interest of prime plus 5.25% but not less than 8.5% (13.90% at September 30, 2024 and 13.90% at December 31, 2023). The additional over advance rider bears a rate of prime plus 12.75%, but not less than 16.00% (25.00% at September 30, 2024 and 18.00% at December 31, 2023). Additionally, the line of credit is subject to a monthly monitoring fee of $1 with a minimum usage requirement on the credit facility. A loan balance of less than $1,500 will bear interest at a rate in line with account receivables advances plus the monthly monitoring fee of $1.

     

    The Company incurred $483 of direct costs of the transaction, consisting primarily of broker, bank and legal fees. These costs have been capitalized and are being amortized over the 3-year life of the ACS agreement. The unamortized debt discount balance was $201 at December 31, 2023. For the nine months ended September 30, 2024, amortization of debt discount was $120, and as of September 30, 2024, the remaining unamortized debt discount balance is $81.

     

    On July 26, 2024, Norman E. Snyder Jr, CEO of the Company, provided a personal guaranty for $500 over advance on our existing line of credit. The over advance was repaid by September 30, 2024.

     

    6. Secured Notes Payable

     

    Amounts outstanding under the Company’s secured convertible notes payable are as follows (amounts in 000’s except share amounts):

     

    Schedule of Secured Convertible Notes Payable

      

    September 30,

    2024

      

    December 31,

    2023

     
    Secured Convertible “Original” Notes Payable (A)  $10,250   $10,250 
    Secured “Option” Notes Payable (B)   6,504    4,050 
    Secured Convertible “Option” Notes Payable   6,504    4,050 
               
    Accrued interest   2,222    1,059 
    Accrued interest on excess debt borrowing   3,234    2,824 
    Capitalized financing costs   (459)   (572)
    Total  $21,751   $17,611 

     

    F-10
     

     

    Secured Notes

     

      (A)

    In May 2022, the Company issued $11,250 of convertible notes payable (the “Original Notes”) to entities affiliated with Whitebox Advisors, LLC (collectively, “Whitebox”). The Original Notes bear interest at 10% per annum (with 5% per annum payable in cash and 5% per annum payable in kind (“PIK”) by adding such PIK interest to the principal amount of the notes), are secured by substantially all of the Company’s assets (including all of its intellectual property) and are subject to a collateral sharing agreement with Alterna Capital (ACS), the Company’s existing secured lender. The Original Notes mature the earlier of September 30, 2025 or the scheduled maturity of any unsecured indebtedness incurred by the Company that is junior in right of payment to Note obligations. At each of September 30, 2024 and December 31, 2023, the principal balance of the Original Notes was $10,250.

     

    Upon conversion or early payment, holders of the Original Notes are entitled to receive an interest make-whole payment, as defined, equal to the sum of the remaining scheduled payments of interest on the Original Notes that would be due at maturity, payable, at the Company’s option, in cash or in shares of common stock. On August 1, 2022, the Original Notes were amended to add a 10% fee (“Excess ABL Fee’) commencing with the fiscal month ending October 31, 2022 for the amount that the Company’s line of credit with ACS exceeds (i) (x) prior to November 30, 2024, $9,500 and (y) on and after November 30, 2024, $6,500, if the Company has not publicly announced or is not actively pursuing a proposed transaction as a result of which the Company reasonably believes that its Common Stock will be listed on a national securities exchange) or $9,500 otherwise, minus (ii) any amounts repaid to ACS pursuant to the Option Notes (not to exceed $500) plus (iii) the aggregate principal amount of Original Notes voluntarily converted into Conversion Consideration (as defined therein), in each case subject to the terms of the collateral sharing agreement; provided that the sum of the amounts in clauses (i), (ii) and (ii) above shall not exceed $10,500 minus any amounts repaid ACS as contemplated by the Option Notes (not to exceed $500).

     

    The Original Notes have an amortization feature which requires the Company to make monthly payments of principal of $200 plus accrued interest, payable in cash or in shares of the Company’s common stock at the option of the Company, based on 90% of the average prices of the Company’s common stock, as defined. During 2023, Whitebox waived the requirement for the Company to pay the December 2022 to October 2023 monthly amortization payments on the Original Notes. The November 2023 amortization payment of $200 principal was paid, and the amortization payment for December 2023 to May 2024 was waived. The amortization period resumed on June 1, 2024.

     

      (B) At the time of issuance of the Original Notes, the Company also granted the investors an option to purchase up to an additional $12,000 aggregate principal amount of “Option Notes”. At December 31, 2023, the principal balance of the Option Notes was $4,050.

     

      On August 1, 2024, the Company entered into an Option Exercise and Nineth Amendment (“Exercise and Amendment Agreement”) to the Notes with Whitebox. Pursuant to the Exercise and Amendment Agreement, holders of the Original Notes exercised an option to purchase an aggregate of approximately $6,504 Option Notes, which consisted of (i) an exchange of $4,050 of existing notes, (ii) additional cash proceeds to the Company of $1,400, and (iii) an additional finance cost of $1,054 The Option Notes mature on the earlier of December 15, 2024, and ninety one days before the schedule maturity of any unsecured indebtedness incurred by the Company that is junior in right of payment to its Note obligations. The Option Notes bear interest in arrears on the outstanding principal amount at a rate of 11.13% per annum, payable in cash. The Option Notes may be prepaid without premium or penalty. Unless $1,400 of the principal amount is prepaid, payment of any Option Note on the maturity date (or due to an acceleration (whether declared or automatic)) shall be accompanied by an additional amount (such amount, the “MOIC Deficiency Amount”), if any, sufficient to achieve a 1.13:1.00 multiple of invested capital since August 1, 2024 (the “MOIC”) on the aggregate principal amount of the Option Notes being paid. The MOIC Deficiency Amount shall be calculated based on (i) the sum of all fees, original issue discount, interest, premiums, principal and other payments received in cash by the applicable holders in respect of the Option Notes since August 1, 2024 (excluding any reimbursement of out-of-pocket costs or expenses reimbursed and any indemnification payments made to the applicable Holders in respect of the Option Notes), as the numerator, and (ii) the aggregate principal amount of the Option Notes on August 1, 2024, as the denominator.

     

     

    F-11
     

     

    Pursuant to the Exercise and Amendment Agreement, Whitebox temporarily waived the specified events of default under the Notes and temporarily waived any requirement that the Company conduct a repurchase of Original Notes in the event of a Make-Whole Fundamental Change (as defined in the Original Notes), subject to the terms and conditions therein.

     

    Waiver of Default

     

    On August 1, 2024, the Whitebox waived the specified events of default under the Original Notes and Option Notes (collectively referred to herein as the “Notes”) and temporarily waived any requirement that the Company conduct a repurchase of Original Notes in the event of a Make-Whole Fundamental Change (as defined in the Original Notes) through December 15, 2024 (See Note 13).

     

    Accrued Interest

     

    At December 31, 2023, the balance of accrued interest was $3,883. During the period ended September 30, 2024, the Company recorded interest of $3,141, made up of $1,832 of interest on the Notes, and $1,309 related to the excess ABL fees and made payments of $514 towards accrued interest and $1,054 was added to the principal of the Option Notes. At September 30, 2024, the balance of accrued interest was $5,456.

     

    Debt Discount

     

    At December 31, 2023, the unamortized debt discount was $572. During the period ended September 30, 2024, the Company incurred $335 of costs for the aforementioned waivers. These costs have been capitalized and are being amortized over the term of the Notes or waiver period. For the nine months ended September 30, 2024, amortization of debt discount was $448, and as of September 30, 2024, the remaining unamortized debt discount balance is $459.

     

    7. Leases Liabilities

     

    During the nine months ended September 30, 2024 and 2023, lease costs totaled $89 and $67, respectively.

     

    As of December 31, 2023, operating lease liabilities totaled $207. During the nine months ended September 30, 2024, the Company made payments of $160 towards its operating lease liability. As of September 30, 2024, operating lease liabilities totaled $47.

     

    As of September 30, 2024, the weighted average remaining lease terms for an operating lease are 0.25 years. As of September 30, 2024, the weighted average discount rate on the operating lease is 12.60%.

     

    On May 10 2024, the Company entered into a new lease with Merritt 7 Ventures LLC, for commercial office space for its corporate headquarters. The lease has an 11-year term and is expected to commence in December 2024. Aggregate monthly base rent for the first year of the lease shall be $8,590. Base rent shall increase incrementally on an annual basis by approximately 3.6%. Customary tax and electricity rent assessments in addition to base rent are payable. In year one, the aggregate of these charges is $7,409 per month. Total payments over the life of the lease are expected to be $2,129.

     

    F-12
     

     

    8. Issuance of Common Stock

     

    During the first quarter of 2024, the Company received $4,097 in gross proceeds from three significant stockholders of the Company, D&D Source of Life Holding LTD (“D&D”) and Union Square Park Partners LP, and John J. Bello, the Company’s former Chairman, pursuant to Simple Agreements for Future Equity (“SAFE”) investments. The SAFE investments were to convert into the next equity financing of Reed’s on the same terms and conditions as investors in Reed’s next equity financing at the lesser of $1.50 per share or the per share price in the financing. D&D was given the right to designate a second independent director nominee to the board of directors of Reed’s and the company agreed to limit the size of its board of directors to nine (9) for so long as D&D owns 25% or more of the equity securities of the Company. The Company initially recorded the SAFE investments as a liability at $5,490 which was reflected on its June 30, 2024 balance sheet, and reflected a loss from change in fair value of SAFE investments of $1,393.

     

    On September 9, 2024, the Company entered into a Securities Purchase Agreement with various purchasers for the issuance of 4,000,000 common shares for total consideration of $6,000. The various purchasers also held the investment in the Company’s SAFEs. As part of the total capital raise, 2,731,205 shares of common stock valued at $4,097 upon conversion of the SAFEs , an additional 1,268,795 common shares were issued to D&D Source of Life Holding Ltd. for consideration of $1,903.

     

    Upon conversion of the SAFE instruments during the three months ended September 30, 2024, the Company recorded a gain from change in fair value of SAFE investments of $1,393.

     

    9. Stock-Based Compensation

     

    Stock Options

     

    The following table summarizes stock option activity during the nine months ended September 30, 2024:

     Schedule of Stock Option Activity

       Shares   Weighted-
    Average
    Exercise Price
       Weighted-
    Average
    Remaining
    Contractual
    Terms
    (Years)
       Aggregate
    Intrinsic
    Value
     
    Outstanding at December 31, 2023   143,000   $45.09    6.75   $     - 
    Granted   -   $-           
    Exercised   -   $-           
    Unvested forfeited   (5,178)  $16,61           
    Vested forfeited   (9,513)  $44.98           
    Outstanding at September 30, 2024   128,309   $46.18    5.97   $- 
    Exercisable at September 30, 2024   112,447   $50.06    5.70   $- 

     

    During the nine months ended September 30, 2024 and 2023, the Company recognized $268 and $351 of compensation expense relating to vested stock options. As of September 30, 2024, the aggregate amount of unvested compensation related to stock options was approximately $105 which will be recognized as an expense as the options vest in future periods through March 28, 2027.

     

    As of September 30, 2024, the outstanding and exercisable options have no intrinsic value. The aggregate intrinsic value was calculated as the difference between the closing market price as of September 30, 2024, which was $1.39, and the exercise price of the outstanding stock options.

     

    F-13
     

     

    10. Stock Warrants

     

    The Company’s warrant activity during the nine months ended September 30, 2024, is as follows:

     Schedule of Warrant Activity

       Shares   Weighted-
    Average
    Exercise
    Price
       Weighted-
    Average
    Remaining
    Contractual
    Terms
    (Years)
       Aggregate
    Intrinsic
    Value
     
                     
    Outstanding at December 31, 2023   549,292   $8.77    2.84   $     - 
    Granted   -    -    -      
    Exercised   -    -    -      
    Forfeited   -    -    -      
    Outstanding at September 30, 2024   549,292   $8.77    2.34   $- 
    Exercisable at September 30, 2024   549,292   $8.77    2.34   $- 

     

    As of September 30, 2024, the outstanding and exercisable warrants have no aggregate intrinsic value. The aggregate intrinsic value was calculated as the difference between the closing market price as of September 30, 2024, which was $1.39, and the exercise price of the Company’s warrants to purchase common stock.

     

    11. Transactions with California Custom Beverage, LLC, former related party

     

    In December 2018, the Company signed a co-packing agreement with California Custom Beverage, LLC’s (“CCB”), an entity owned by Christopher J. Reed, a former related party, pursuant to which CCB agreed to produce certain products for the Company for agreed fees. The co-packing agreement, as amended, includes certain provisions for product inputs, shrinkage, and quality assurance. Also beginning in 2019, CCB agreed to pay the Company a 5% royalty through 2021 on certain private label sales made by CCB.

     

    At September 30, 2024 and 2023, accounts receivable due from and accounts payable due to CCB were as follows:

     Schedule of Related Parties

       September 30,
    2024
       December 31,
    2023
     
    Accounts receivable, net of provision of $1,123 and $1,123 at September 30, 2024 and December 31, 2023, respectively   259    259 
    Accounts payable   (211)   (259)
    Net (payable) receivable   48    - 

     

    In addition, on April 19, 2023, the Company received a letter from CCB demanding payment of various amounts, including the $452 and $452 outstanding at September 30, 2024 and December 31, 2023, respectively. The Company has determined that the probability of realizing any loss on the demand from CCB is remote and therefore has not recorded any additional accruals related to the demand.

     

    12. Commitments and Contingencies

     

    During 2023, the firm engaged an investment bank to explore financing options for the Company. We have a maximum obligation of $1.2M in fees so far in this engagement. These fees will be recognized on a success basis and will be paid out only if a transaction is finalized.

     

    In 2018, CCB assumed the monthly payments on our lease obligation for a Los Angeles manufacturing plant for payments through September 2024, and our release from the obligation by the lessor, however, is dependent upon CCB’s deposit of $1,200 of security with the lessor. As of September 30, 2024, $800 has been deposited with the lessor and Chris J. Reed has placed approximately 7,260 shares of the Company’s common stock valued at $10 that remain in escrow with the lessor.

     

    F-14
     

     

    We are, and from time to time, we be a party to claims and legal proceedings arising in the ordinary course of business. Our management evaluates our exposure to these claims and proceedings individually and in the aggregate and provides for potential losses on such litigation if the amount of the loss is estimable and the loss is probable.

     

    We believe that there are no material litigation matters at the current time. Although the result of such litigation matters and claims cannot be predicted with certainty, we believe that the final outcome of such claims and proceedings will not have a material adverse impact on our financial position, liquidity, or results of operations.

     

    13. Subsequent Events

     

      a) Convertible notes

     

    On October 10, 2024, Whitebox sold and assigned its entire interest in eight secured promissory notes (the “Notes”) (Note 6) of the Company to the Company’s majority stockholder, D&D. The Notes contain customary affirmative and negative covenants and events of default. The Notes were secured by substantially all of the Company’s assets, including all intellectual property.

     

    On November 14, 2024, the Company entered into a new secured one-year term loan with a principal amount of $10 million with Whitebox. The loan bears interest of 8% which is payable quarterly. The term loan is secured by substantially all of the Company’s assets, including all intellectual property. The Company used part of the proceeds to pay off and close its existing revolving line of credit (Note 5).

     

    On November 14, 2024, in conjunction with the term loan transaction, D&D and the Company amended the Notes. D&D released all collateral under the Notes, deferred cash payments thereunder and extended the maturity dates of all of the Notes to 181 days after the maturity of the revolving credit facility, which is November 14, 2025 (with the maturity dates of the notes extended to May 14, 2026).

     

      b) Board of Directors

     

    On October 21, 2024, the board of directors of the Company, upon recommendation from its governance committee, appointed Sam Van to serve as a member of its board of directors. Mr. Van is an independent director designee of D&D.

     

    On October 28, John J. Bello and Louis Imbrogno, Jr. resigned from the board of directors (“board”) of the Company. Prior to resignation, Mr. Bello had served as the Chairman of the board and a member of its operating committee. Mr. Imbrogno had served on the governance committee and audit committee and as chair of the compensation committee

     

    On October 29, Thomas W. Kosler also resigned from the board. He had served as chair of the audit committee.

     

    F-15
     

     

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     

    Our discussion and analysis is intended to help the reader understand our results of operations and financial condition and is provided as an addition to, and should be read in connection with, our condensed financial statements and the accompanying notes. Cautionary statements on page [ii] of this report and in “Part I, Item 1A. Risk Factors” of our 2023 Form 10-K as updated by “Part II, Item 1A” of this report, should be considered when evaluating our trends and future results.

     

    In addition to our GAAP results, the following discussion includes Modified EBITDA as a supplemental measure of our performance. We present Modified EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Modified EBITDA in developing our internal budgets, forecasts, and strategic plan; in analyzing the effectiveness of our business strategies in evaluating potential acquisitions; making compensation decisions; and in communications with our board of directors concerning our financial performance. Modified EBITDA is not a recognized measurement under GAAP and should not be considered as an alternative to net income, income from operations or any other performance measure derived in accordance with GAAP, or as an alternative to cash flow from operating activities as a measure of liquidity. We define Modified EBITDA as net income (loss), plus interest expense, depreciation and amortization, stock-based compensation, changes in fair value of warrant expense, and one-time restructuring-related costs including employee severance and asset impairment.

     

    The following discussion also includes the use of gross billing, a key performance indicator and metric. Gross billing represents invoiced amounts to distributors and retailers, excluding sales adjustments. Gross billing may include deductions from MSRP or “list price”, where applicable, and excludes promotional costs of generating such sales. Management utilizes gross billing to monitor operating performance of products and salespersons, which performance can be masked by the effect of promotional or other allowances. Management believes that the presentation of gross billing provides a useful measure of Reed’s operating performance.

     

    Amounts presented in the discussion below are in thousands, except share and per share amounts.

     

    Results of Operations

     

    Overview

     

    During the nine months ended September 30, 2024, the Company continued to focus on strengthening its supply chain, implement gross margin enhancement initiatives, drive efficiencies in transportation and warehouse costs and reduce operating expenses. In addition, it continues to build its innovation pipeline with sustained growth in Reed’s Real Ginger Ale, Virgil’s Zero Sugar handcrafted sodas, Reed’s Classic and Stormy Mule, and Reed’s Hard Ginger Ale.

     

    The Company remains engaged on driving sales growth, improving gross margin, and reducing freight costs. The sales growth focus is on channel expansion, increase in store placements, new product introduction and improved sales execution. The margin enhancement initiative is driven by packaging savings, co-packer upgrades, and better leveraged purchasing and improved efficiency. Underpinning these initiatives is a focus on strategically reducing operating costs particularly delivery and handling expenses. In addition, the Company continues to augment its co-packer network to drive further efficiencies and build proper levels of inventory at the appropriate location to maximize delivery metrics.

     

    Recent Trends – Market Conditions

     

    Although the U.S. economy continued to grow throughout 2023 and into Q3 2024, the higher inflation, the actions by the Federal Reserve to address inflation, and rising energy prices create uncertainty about the future economic environment which will continue to evolve and may impact our business in future periods. We have experienced supply chain challenges, including increased lead times, as well as inflation of raw materials, logistics and labor costs due to availability constraints and high demand. Although we regularly monitor companies in our supply chain, and use alternative suppliers when necessary and available, supply chain constraints could cause a disruption in our ability to obtain raw materials required to manufacture our products and adversely affect our operations.

     

    1
     

     

    During the three months ending September 30, 2024, the Company continued to experience moderation from the elevated freight costs experienced in 2023. The average cost of shipping and handling for the three months ended September 30, 2024, was $2.99 as compared to $2.98 in the three months ended September 30, 2023. During the nine months ended September 30, 2024, the average cost of shipping and handling was $2.66 per case, as compared to $3.17 per case for the nine months ended September 30, 2023. Although the Company has experienced decreases in freight costs over the last four quarters, in the Company’s opinion there remains a volatile environment and the Company will continue to monitor pricing and availability in transportation. Mitigation plans have been implemented to manage this risk. The Company has been negatively impacted by supply chain challenges affecting our ability to benefit from strong demand for, and increased sales of our product. The disruption caused by labor shortages, significant raw material cost inflation, logistics issues and increased freight costs, and ongoing port congestion, resulted in suppressed margins. The Company has experienced moderation in inflation and anticipates this to continue throughout 2024.

     

    Results of Operations – Three Months Ended September 30, 2024, as compared to Three Months Ended September 30, 2023

     

    The following table sets forth key statistics for the three months ended September 30, 2024 and 2023, respectively, in thousands.

     

      

    Three Months Ended

    September 30,

       Pct. 
       2024   2023   Change 
    Gross billing (A)  $8,901   $13,219    -33%
    Less: Promotional and other allowances (B)   2,149    1,363    58%
    Net sales  $6,752   $11,856    -43%
                    
    Cost of goods sold   5,537    7,823    -29%
    % of Gross billing   62%   59%     
    % of Net sales   82%   66%     
    Gross profit  $1,215   $4,033    -70%
    % of Net sales   18%   34%     
                    
    Expenses               
    Delivery and handling  $1,279   $1,908    -33%
    % of Net sales   19%   16%     
    Dollar per case ($)  $2.99   $2.98      
    Selling and marketing   1,283    861    49%
    % of Net sales   19%   7%     
    General and administrative   1,791    1,407    27%
    % of Net sales   27%   12%     
    Total operating expenses   4,353    4,176    4%
                    
    Loss from operations  $(3,138)  $(143)   2,094%
                    
    Interest expense and other income (expense)  $(1,012)  $(1,293)   -22%
                    
    Net loss  $(4,150)  $(1,436)   189%
                    
    Loss per share – basic and diluted  $(0.82)  $(0.34)   138%
                    
    Weighted average shares outstanding - basic & diluted   5,066,412    4,169,131    22%

     

    2
     

     

    (A) We define gross billing as the total sales for the Company unadjusted for costs related to generating those sales. Management utilizes gross billing as an indicator of and to monitor operating performance of products and salespersons before the effect of any promotional or other allowances, which are determined in accordance with GAAP, and can mask certain performance issues. We believe that the presentation of gross billing provides a useful measure of our operating performance. Additionally, gross billing may not be comparable to similarly titled measures used by other companies, as gross billing has been defined by our internal reporting practices.

     

    (B) We define promotional and other allowances as costs deducted from gross billing which are associated with generating those sales. Management utilizes promotional and other allowances as an indicator of and to monitor operating performance of products, salespersons, and customer agreements. We believe that the presentation of promotional and other allowances provides a useful measure of our operating performance. The presentation of promotional and other allowances facilitates an evaluation of their impact on the determination of net sales and the spending levels incurred or correlated with such sales. The expenditures described in this line item are determined in accordance with GAAP and meet GAAP requirements, the disclosure thereof does not conform to GAAP presentation requirements. Additionally, our definition of promotional and other allowances may not be comparable to similar items presented by other companies. Promotional and other allowances primarily include consideration given to the Company’s distributors or retail customers including, but not limited to the following: (i) reimbursements given to the Company’s distributors for agreed portions of their promotional spend with retailers, including slotting, shelf space allowances and other fees for both new and existing products; (ii) the Company’s agreed share of fees given to distributors and/or directly to retailers for in-store marketing and promotional activities; (iii) the Company’s agreed share of slotting, shelf space allowances and other fees given directly to retailers; (iv) incentives given to the Company’s distributors and/or retailers for achieving or exceeding certain predetermined sales goals; and (v) discounted or free products. Promotional and other allowances constitute a material portion of our marketing activities. The Company’s promotional allowance programs with its numerous distributors and/or retailers are executed through separate agreements in the ordinary course of business. These agreements generally provide for one or more of the arrangements described above and are of varying durations, ranging from one week to one year.

     

    Sales, Cost of Sales, and Gross Margins

     

    The following chart sets forth key statistics for the transition of the Company’s top line activity from the third quarter of 2023 through the third quarter of 2024.

     

          2024       2023       Q3 Per Case       Sept YTD Per Case     
          Q1   Q2   Q3   YTD   Q3 vs PY   YTD vs PY   Q1   Q2   Q3   YTD   2024   2023   vs PY   2024   2023   vs PY 
    Cases:                                                                                   
       Reed’s   348    413    253    1,014    -37%   -10%   370    355    402    1,127                               
       Virgil’s   151    239    175    565    -26%   -16%   241    197    238    676                               
       Total Core   499    652    428    1,579    -33%   -12%   611    552    640    1,803                               
       Non Core   -    -    -    -    -%   -100%   2    -    -    2                               
       Total   499    652    428    1,579    -33%   -13%   613    552    640    1,805                               
                                                                                        
    Gross Billing:                                                                                   
       Core  $10,377   $13,584   $8,901   $32,862    -33%   -10%  $12,333   $11,095   $13,197   $36,626   $20.8   $20.6    1%  $20.8   $20.3    2%
       Non Core   2    -    -    2    -100%   -99%   120    69    22    211   $-   $-    -%   -    .1    -99%
       Total  $10,379   $13,584   $8,904   $32,864    -33%   -11%  $12,453   $11,164   $13,219   $36,837   $20.8   $20.7    1%   20.8    20.4    2%
                                                                                        
    Discounts:  Total  $(784)  $(1,710)  $(2,149)  $(4,643)   58%   22%  $(1,296)  $(1,159)  $(1,363)  $(3,819)  $(5.0)  $(2.1)   136%  $(2.9)  $(2.1)   39%
                                                                                        
    COGS:                                                                                   
       Core  $(6,182)  $(8,043)  $(5,537)  $(19,762)   -29%   -16%  $(8,422)  $(7,408)  $(7,820)  $(23,650)  $(12.9)  $(12.2)   6%  $(12.5)  $(13.1)   -5%
       Non Core   -    -    -    -    -100%   -100%   (87)   (88)   (3)   (128)   -    -    -%   -    .1    -5%
       Total  $(6,182)  $(8,043)  $(5,530)  $(19,762)   -29%   -17%  $(8,459)  $(7,496)  $(7,823)  $(23,778)  $(12.9)  $(12.2)   6%  $(12.5)  $(13.2)   -5%
                                                                                        
    Gross Margin:     $3,413   $3,831   $1,215   $8,459    -70%   7%  $2,698   $2,509   $4,033   $9,240   $2.9   $6.3    -55%  $5.4   $5.1    5%
    as % Net Sales      36%   32%   18%   30%             24%   25%   34%   28%                              

     

    3
     

     

    Sales, Cost of Sales, and Gross Margins

     

    As part of the Company’s ongoing initiative to simplify and streamline operations, the Company has identified core products on which to place its strategic focus. These core products consist of Reed’s and Virgil’s branded beverages. Non-core products consist primarily of Wellness Shots, candy and slower selling discontinued Reed’s and Virgil’s SKUs.

     

    Core beverage volume for the three months ended September 30, 2024, represents 100% of all beverage volume.

     

    Core brand gross billing decreased by 33% to $8,901 compared to $13,197 during the same period last year, driven by a Reed’s volume decrease of 37% and Virgil’s volume decrease of 26%. The result is a decrease in total gross billing of 33%, to $8,901 during the three months ended September 30, 2023, from $13,219 in the same period last year. Prices on our core brands increased 1% to $20.79 per case. The lower gross billings was a result of volume declines that have impacted the carbonated soft drink segment as a result of price increases coupled with the Company’s inability to produce sufficient levels of inventory to meet current demand as a result of tighter credit terms from suppliers.

     

    Discounts as a percentage of gross sales was 24% compared to 10% in the same period last year. As a result, net sales revenue decreased 43% in the three months ended September 30, 2024, to $6,752, compared to $11,856 in the same period last year driven by lower sales and elevated trade spend.

     

    Cost of Goods Sold

     

    Cost of goods sold decreased $2,286 during the three months ended September 30, 2024, as compared to the same period last year. As a percentage of net sales, cost of goods sold for the three months ended September 30, 2024, was 82% as compared to 66% for the same period last year. The decline as a percentage of net sales, was driven by elevated trade spend, partially offset by lower supply chain and input costs.

     

    The total cost of goods per case increased to $12.91 per case in the three months ended September 30, 2024, from $12.22 per case for the same period last year.

     

    Gross Margin

     

    Gross margin was 18% for the three months ended September 30, 2024, compared to 34% for the same period last year.

     

    Operating Expenses

     

    Delivery and Handling Expenses

     

    Delivery and handling expenses consist of delivery costs to customers and warehousing costs incurred for handling our finished goods after production. Delivery and handling expenses decreased by $629 in the three months ended September 30, 2024, to $1,279 from $1,908 in the same period last year, driven by our efforts to mitigate inflationary costs. Delivery costs in the three months ended September 30, 2024, were 19% of net sales and $2.99 per case, compared to 16% of net sales and $2.98 per case during the same period last year.

     

    Selling and Marketing Expenses

     

    Marketing expenses consist of direct marketing, marketing labor, and marketing support costs. Selling expenses consist of all other selling-related expenses including personnel and contractor support. Total selling and marketing expenses were $1,283 during the three months ended September 30, 2024, compared to $861 during the same period last year, an increase of $422. As a percentage of net sales, selling and marketing costs was 19% during the three months ended September 30, 2024, as compared to 7% during the same period last year. The increase was primarily driven by higher employee related costs, marketing spend, and higher service fees related to e-commerce sales.

     

    General and Administrative Expenses

     

    General and administrative expenses consist primarily of the cost of executive, administrative, and finance personnel, as well as professional fees. General and administrative expenses increased in the three months ended September 30, 2024 to $1,791 from $1,407, an increase of $384 over the same period last year. As a percentage of net sales, general and administrative expenses were 27% during the three months ended September 30, 2024, as compared to 12% during the same period last year. The increase was driven by higher professional fees, bad debt expense, investor related costs and employee related costs.

     

    4
     

     

    Loss from Operations

     

    The loss from operations was $3,138 for the three months ended September 30, 2024, as compared to a loss of $143 in the same period last year driven by decreased gross profit and an increase in operating expenses discussed above.

     

    Interest and Other Expense

     

    Interest and other expense for the three months ended September 30, 2024, consisted of $1,012 of interest expense. During the same period last year, interest and other expense consisted of $1,293 of interest expense.

     

    Modified EBITDA

     

    In addition to our GAAP results, we present Modified EBITDA as a supplemental measure of our performance. However, Modified EBITDA is not a recognized measurement under GAAP and should not be considered as an alternative to net income, income from operations or any other performance measure derived in accordance with GAAP, or as an alternative to cash flow from operating activities as a measure of liquidity. We define Modified EBITDA as net income (loss), plus interest expense, tax expense, depreciation and amortization, stock-based compensation, changes in fair value of warrant expense, change in fair value of SAFE agreements, legal and insurance settlements, non-recurring professional fees inventory write-offs associated with exited categories and major packaging and formula changes, one-time changes in policy, impact of changes to accounting methodology and one-time restructuring-related costs including employee severance and asset impairment.

     

    Management considers our core operating performance to be that which our managers can affect in any particular period through their management of the resources that affect our underlying revenue and profit generating operations during that period. Non-GAAP adjustments to our results prepared in accordance with GAAP are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Modified EBITDA, you should be aware that in the future we may incur expenses that are the same as or similar to some of the adjustments in this presentation. Our presentation of Modified EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.

     

    Set forth below is a reconciliation of net loss to Modified EBITDA for the three months ended September 30, 2024 and 2023 (unaudited; in thousands):

     

      

    Three Months Ended

    September 30

     
       2024   2023 
    Net loss  $(4,150)  $(1,436)
               
    Modified EBITDA adjustments:          
    Depreciation and amortization   71    68 
    Tax expense   (8)   - 
    Interest expense   2,405    1,293 
    Change in fair value of SAFE investments   (1,393)   - 
    Production quality hold write-down   15    - 
    Stock option and other noncash compensation   46    139 
    Professional fees   -    - 
    Severance   16    85 
    Legal settlements   -    12 
    Total EBITDA adjustments  $1,152   $1,597 
               
    Modified EBITDA  $(2,998)  $161 

     

    5
     

     

    We present Modified EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Modified EBITDA in developing our internal budgets, forecasts and strategic plan; in analyzing the effectiveness of our business strategies in evaluating potential acquisitions; making compensation decisions; and in communications with our board of directors concerning our financial performance. Modified EBITDA has limitations as an analytical tool, which includes, among others, the following:

     

      ● Modified EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments;
         
      ● Modified EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
         
      ● Modified EBITDA does not reflect future interest expense, or the cash requirements necessary to service interest or principal payments, on our debts; and
         
      ● Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Modified EBITDA does not reflect any cash requirements for such replacements.

     

    Results of Operations – Nine months ended September 30, 2024, as compared to Nine Months Ended September 30, 2023

     

    The following table sets forth key statistics for the nine months ended September 30, 2024 and 2023, respectively, in thousands.

     

       Nine Months Ended September 30,   Pct. 
       2024   2023   Change 
    Gross billing (A)  $32,864   $36,837    -11%
    Less: Promotional and other allowances (B)   4,643    3,819    22%
    Net sales  $28,221   $33,018    -15%
                    
    Cost of goods sold   19,762    23,778    -17%
    % of Gross billing   60%   65%     
    % of Net sales   70%   72%     
    Gross profit  $8,459   $9,240    -8%
    % of Net sales   30%   28%     
                    
    Expenses               
    Delivery and handling  $4,204   $5,714    -26%
    % of Net sales   15%   17%     
    Dollar per case ($)   2.66    3.17      
    Selling and marketing   3,473    3,567    -3%
    % of Net sales   12%   11%     
    General and administrative   5,239    4,427    18%
    % of Net sales   19%   13%     
    Total operating expenses   12,916    13,708    -6%
                    
    Loss from operations  $(4,457)  $(4,468)   0%
                    
    Interest expense and other income (expense)   (4,578)   (4,459)   3%
                    
    Net loss  $(9,035)  $(8,927)   1%
                    
    Loss per share – basic and diluted  $(2.02)  $(2.69)   -25%
                    
    Weighted average shares outstanding - basic & diluted   4,483,587    3,322,959    35%

     

    6
     

     

      (A) We define gross billing as the total sales for the Company unadjusted for costs related to generating those sales. Management utilizes gross billing as an indicator of and to monitor operating performance of products and salespersons before the effect of any promotional or other allowances, which are determined in accordance with GAAP, and can mask certain performance issues. We believe that the presentation of gross billing provides a useful measure of our operating performance. Additionally, gross billing may not be comparable to similarly titled measures used by other companies, as gross billing have been defined by our internal reporting practices.
         
      (B) We define promotional and other allowances as costs deducted from gross billing which are associated with generating those sales. Management utilizes promotional and other allowances as an indicator of and to monitor operating performance of products, salespersons, and customer agreements. We believe that the presentation of promotional and other allowances provides a useful measure of our operating performance. The presentation of promotional and other allowances facilitates an evaluation of their impact on the determination of net sales and the spending levels incurred or correlated with such sales. The expenditures described in this line item are determined in accordance with GAAP and meet GAAP requirements, the disclosure thereof does not conform to GAAP presentation requirements. Additionally, our definition of promotional and other allowances may not be comparable to similar items presented by other companies. Promotional and other allowances primarily include consideration given to the Company’s distributors or retail customers including, but not limited to the following: (i) reimbursements given to the Company’s distributors for agreed portions of their promotional spend with retailers, including slotting, shelf space allowances and other fees for both new and existing products; (ii) the Company’s agreed share of fees given to distributors and/or directly to retailers for in-store marketing and promotional activities; (iii) the Company’s agreed share of slotting, shelf space allowances and other fees given directly to retailers; (iv) incentives given to the Company’s distributors and/or retailers for achieving or exceeding certain predetermined sales goals; and (v) discounted or free products. Promotional and other allowances constitute a material portion of our marketing activities. The Company’s promotional allowance programs with its numerous distributors and/or retailers are executed through separate agreements in the ordinary course of business. These agreements generally provide for one or more of the arrangements described above and are of varying durations, ranging from one week to one year.

     

    Sales, Cost of Sales, and Gross Margins

     

    As part of the Company’s ongoing initiative to simplify and streamline operations the Company has identified core products on which to place its strategic focus. These core products consist of Reed’s and Virgil’s branded beverages. Non-core products consist primarily of Wellness Shots, candy and slower selling discontinued Reed’s and Virgil’s SKUs.

     

    Core beverage volume for the nine months ended September 30, 2024, represents 100% of all beverage volume.

     

    Core brand gross billing decreased by 10% to $32,864 compared to $36,626 during the same period last year, driven by Reed’s volume decline of 10% and Virgil’s volume decline of 16%. The result is a decrease in total gross billing of 11%, to $32,864 during the nine months ended September 30, 2024, from $36,837 in the same period last year. Price on our core brands increased 1% to $20.81 per case. The lower gross billings was a result of volume declines that have impacted the carbonated soft drink segment as a result of price increases coupled with the Company’s inability to produce sufficient levels of inventory to meet current demand as a result of tighter credit terms from suppliers.

     

    Discounts as a percentage of gross sales was 14% compared to 10% in the same period last year. As a result, net sales revenue decreased 15% in the nine months ended September 30, 2024, to $28,221, compared to $33,018 in the same period last year driven by lower sales and elevated trade spend.

     

    7
     

     

    Cost of Goods Sold

     

    Cost of goods sold decreased $4,016 during the nine months ended September 30, 2024, as compared to the same period last year. As a percentage of net sales, cost of goods sold for the nine months ended September 30, 2024, was 70% as compared to 72% for the same period last year. The decrease was driven by lower supply chain and input costs.

     

    The total cost of goods per case decreased to $12.52 per case in the nine months ended September 30, 2024, from $13.17 per case for the same period last year. The cost of goods sold per case on core brands was $12.51 during the nine months ended September 30, 2024, compared to $13.11 for the same period last year.

     

    Gross Margin

     

    Gross margin increased to 30% for the nine months ended September 30, 2024, compared to 28% for the same period last year.

     

    Operating Expenses

     

    Delivery and Handling Expenses

     

    Delivery and handling expenses consist of delivery costs to customers and warehousing costs incurred for handling our finished goods after production. Delivery and handling expenses decreased by $1,510 in the nine months ended September 30, 2024, to $4,204 from $5,714 in the same period last year, driven by our efforts to mitigate inflationary costs. Delivery costs in the nine months ended September 30, 2024, were 15% of net sales and $2.66 per case, compared to 17% of net sales and $3.17 per case during the same period last year.

     

    Selling and Marketing Expenses

     

    Marketing expenses consist of direct marketing, marketing labor, and marketing support costs. Selling expenses consist of all other selling-related expenses including personnel and contractor support. Total selling and marketing expenses were $3,473 during the nine months ended September 30, 2024, compared to $3,567 during the same period last year. As a percentage of net sales, selling and marketing expenses were 12% of net sales during the nine months ended September 30, 2024, as compared to 11% of net sales during the same period last year. The decrease was driven by lower co-op advertising fees, employee related costs and marketing spend partially offset by higher broker fees and e-commerce delivery costs.

     

    General and Administrative Expenses

     

    General and administrative expenses consist primarily of the cost of executive, administrative, and finance personnel, as well as professional fees. General and administrative expenses increased in the nine months ended September 30, 2024, to $5,239 from $4,427, an increase of $812 over the same period last year. The increase was driven by higher employee related costs, legal settlement related costs, professional fees, and quality assurance costs spending partially offset by lower public company costs.

     

    Loss from Operations

     

    The loss from operations was $4,457 for the nine months ended September 30, 2024, as compared to a loss of $4,468 in the same period last year driven by increased gross profit and decreased operating expenses discussed above.

     

    Interest and Other Expense

     

    Interest and other expense for the nine months ended September 30, 2024, consisted of $4,578 of interest expense. During the same period last year, interest and other expense consisted of $4,459 of interest expense.

     

    8
     

     

    Modified EBITDA

     

    In addition to our GAAP results, we present Modified EBITDA as a supplemental measure of our performance. However, Modified EBITDA is not a recognized measurement under GAAP and should not be considered as an alternative to net income, income from operations or any other performance measure derived in accordance with GAAP, or as an alternative to cash flow from operating activities as a measure of liquidity. We define Modified EBITDA as net income (loss), plus interest expense, tax expense, depreciation and amortization, stock-based compensation, changes in fair value of warrant expense, change in fair value of SAFE agreements, legal and insurance settlements, non-recurring professional fees inventory write-offs associated with exited categories and major packaging and formula changes, one-time changes in policy, impact of changes to accounting methodology and one-time restructuring-related costs including employee severance and asset impairment.

     

    Management considers our core operating performance to be that which our managers can affect in any particular period through their management of the resources that affect our underlying revenue and profit generating operations during that period. Non-GAAP adjustments to our results prepared in accordance with GAAP are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Modified EBITDA, you should be aware that in the future we may incur expenses that are the same as or similar to some of the adjustments in this presentation. Our presentation of Modified EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.

     

    Set forth below is a reconciliation of net loss to Modified EBITDA for the nine months ended September 30, 2024 and 2023 (unaudited; in thousands):

     

       Nine Months Ended September 30, 
       2024   2023 
    Net loss  $(9,035)  $(8,927)
               
    Modified EBITDA adjustments:          
    Depreciation and amortization   209    214 
    Income taxes   67    - 
    Interest expense   4,578    4,459 
    Product quality hold write-down   44    - 
    Stock option and other noncash compensation   268    354 
    Professional fees   334    - 
    Severance expense   42    177 
    Legal settlements   170    12 
    Total EBITDA adjustments  $5,712   $5,216 
               
    Modified EBITDA  $(3,323)  $(3,711)

     

    We present Modified EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Modified EBITDA in developing our internal budgets, forecasts and strategic plan; in analyzing the effectiveness of our business strategies in evaluating potential acquisitions; making compensation decisions; and in communications with our board of directors concerning our financial performance. Modified EBITDA has limitations as an analytical tool, which includes, among others, the following:

     

      ● Modified EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments;
         
      ● Modified EBITDA does not reflect changes in, or cash requirements for, our working capital needs;

     

    9
     

     

      ● Modified EBITDA does not reflect future interest expense, or the cash requirements necessary to service interest or principal payments, on our debts; and
         
      ● Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Modified EBITDA does not reflect any cash requirements for such replacements.

     

    Going Concern

     

    The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, for the nine months ended September 30, 2024, the Company recorded a net loss of $9,035, and utilized $2,254 of cash in operations and at September 30, 2024, had a working capital deficiency of $22,923 and a stockholders’ deficit of $21,953. As of September 30, 2024, the Company borrowed $5,390 on its line of credit and owed $21,751 on its Notes (See Note 5 and Note 6 for further detail). These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. The financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

     

    As of September 30, 2024, we had a cash balance of $306, no availability under our line of credit and $7,529 of additional borrowing capacity from the credit facility assuming there is availability under the terms.

     

    On July 26, 2024, Norman E. Snyder Jr, CEO of the Company, provided a personal guaranty for a $500 over advance on our existing line of credit with ACS. On August 1, 2024, the Company funded $1,400 pursuant to an option exercise by Whitebox under the Option Notes.

     

    Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. To alleviate these conditions, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic partners or through obtaining credit from financial institutions. The Company is continuing to discuss the restructuring of debt with existing lenders and is exploring new financing opportunities to address the line of credit which comes due in March 2025 (see Note 5) and the portion of debt under the Notes that is due on December 15, 2024 (see Note 6). As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.

     

    We have also taken decisive action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating improved vendor contracts and restructuring our selling prices.

     

    Notes Payable and Existing Financing

     

    Please refer to Notes 5 and 6 in the accompanying condensed financial statements for a description of our existing line of credit agreement and outstanding notes payable.

     

    Critical Accounting Policies and Estimates

     

    The preparation of the Company’s financial statements in conformity with generally accepted accounting principles in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of those judgments can be subjective and complex, and therefore, actual results could differ materially from those estimates under different assumptions or conditions. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates. Significant estimates include those related to assumptions used in estimates for reserves of uncollectible accounts, inventory obsolescence, depreciable lives of property and equipment, analysis of impairments of recorded long-term tangible and intangible assets, realization of deferred tax assets, accruals for potential liabilities and assumptions made in valuing stock instruments issued for services. There were no changes to our critical accounting policies described in the condensed financial statements included in our 2023 10-K that impacted our condensed financial statements and related notes included herein.

     

    10
     

     

    Recent Accounting Pronouncements

     

    See Note 2 of the Notes to Condensed Financial Statements for a discussion of recent accounting pronouncements.

     

    Item 3. Quantitative and Qualitative Disclosures About Market Risk.

     

    A smaller reporting company is not required to provide the information required by this Item.

     

    Item 4. Controls and Procedures.

     

    Evaluation of Disclosure Controls and Procedures

     

    Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we conducted an evaluation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of September 30, 2024, to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.

     

    Changes in Internal Control Over Financial Reporting

     

    There have been no changes in the Company’s internal control over financial reporting during the three months ended September 30, 2024 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

     

    PART II – OTHER INFORMATION

     

    Item 1. Legal Proceedings

     

    We are currently, and from time to time, may be continue to be subject to a variety of variety of litigation, claims, legal or regulatory proceedings, inquiries and investigations from time to time in the ordinary course of business. Management evaluates, and periodically re-evaluates, whether the final result of any of the foregoing may be expected to have a material adverse effect on our financial condition, results of operations or cash flows. Management has determined that no disclosure is required under this Item 1.

     

    Item 1A. Risk Factors

     

    There have been no material changes with respect to the risk factors disclosed in our 2023 Form 10-K.

     

    Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

     

    None that have not been previously disclosed in a Current Report on Form 8-K.

     

    Item 3. Defaults Upon Senior Securities

     

    None.

     

    Item 4. Mine Safety Disclosures

     

    Not applicable.

     

    11
     

     

    Item 5. Other Information

     

    Trading Plans

     

    During the fiscal quarter ended September 30, 2024, none of our directors or officers (as defined in Rule 16a-1(f) under the Act) informed us of the adoption or termination of a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408 of Regulation S-K.

     

    Item 6. Exhibits

     

    See Exhibit Index on page. 13.

     

    INDEX TO EXHIBITS

    ITEM 15(a)(3)

     

    The following is a list of the exhibits filed as part of this Form 10-Q. The documents incorporated by reference can be viewed on the SEC’s website at http://www.sec.gov.

     

    Exhibit

     

    3(i) Certificate of Incorporation of Reeds, Inc. which is incorporated herein by reference to exhibit 3(iv) to Form 10-K filed with SEC on May 15, 2023.
    3(ii) Amended and Restated Bylaws of Reed’s, Inc. which is incorporated by reference to Exhibit 3.8 to Form 10-K/A filed with the SEC on April 8, 2020.
    4.1 Form of Option Note in favor of Wilmington Savings Fund Society, FSB dated August 1, 2024, which is incorporated by reference to Exhibit 4.1 to Form 10-Q filed with the SEC on August 13, 2024
    10.1 Option Exercise and Sixth Amendment to the 10% Secured Convertible Notes by and between Reed’s, Inc. and each holder and Wilmington Savings Fund Society, FSB, holder representative and collateral agent dated August 1, 2024, which is incorporated by reference to Exhibit 10.1 to Form 10-Q filed with the SEC on August 13, 2024.
    10.2

    Securities Purchase Agreement by and between Reed’s, Inc. and investors dated September 9, 2024, which is incorporated by reference to Exhibit 10.1 to Form 8-K filed with the SEC on September 13, 2024.

    10.3

    Registration Rights Agreement by and between Reed’s, Inc. and investors dated September 9, 2024, which is incorporated by reference to Exhibit 10.2 to Form 8-K filed with the SEC on September 13, 2024.
    31 Certification of our Chief Executive Officer and our Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
    32 Certification of our Chief Executive Officer and our Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
    101 The following materials from Reed’s, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Balance Sheets, (ii) the Condensed Statements of Operations, (iii) the Condensed Statements of Changes in Stockholders (Deficit), (iv) the Condensed Statements of Cash Flows, and (v) Notes to Condensed Financial Statements.
    104 The cover page from the Reed’s, Inc. Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, formatted in Inline XBRL and contained in Exhibit 101.

     

    12
     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

     

      Reed’s, Inc.
      (Registrant)
       
    Date: November 14, 2024 /s/ Norman E. Snyder, Jr.
      Norman E. Snyder, Jr.
      Chief Executive Officer
      (Principal Executive Officer)
       
    Date: November 14, 2024 /s/ Joann Tinnelly
      Joann Tinnelly
      Chief Financial Officer
      (Principal Financial Officer)

     

    13

     

    Get the next $REED alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $REED

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $REED
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Johnson Keith William

    3 - REED'S, INC. (0001140215) (Issuer)

    11/13/25 4:03:38 PM ET
    $REED

    SEC Form 3 filed by new insider Tu Michael Carl

    3 - REED'S, INC. (0001140215) (Issuer)

    9/29/25 4:51:23 PM ET
    $REED

    SEC Form 3 filed by new insider Reejsinghani Tina Suman

    3 - REED'S, INC. (0001140215) (Issuer)

    9/29/25 4:50:13 PM ET
    $REED

    $REED
    Leadership Updates

    Live Leadership Updates

    View All

    Reed's, Inc. Announces Appointment of Neal Cohane as Chief Operating Officer

    NORWALK, Conn., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Reed's, Inc. (NYSE:REED) ("Reed's" or the "Company"), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, today announced the appointment of Neal Cohane as Chief Operating Officer, effective January 5, 2026. Mr. Cohane brings decades of leadership experience across the beverage industry and a proven track record of building high-performing commercial organizations, scaling national distribution, and driving sustainable growth for consumer brands. Most recently, he served as Chief Sales Officer at Eastroc Beverages and previously founded Rootstock Brands, Inc., where he advised beverage companies on go-to-mar

    12/29/25 4:30:00 PM ET
    $REED

    Reed's Appoints Joann Tinnelly as Chief Financial Officer

    NORWALK, Conn., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Reed's, Inc. (OTCQX:REED) ("Reed's" or the "Company"), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, today announced that Interim Chief Financial Officer (CFO) Joann Tinnelly has transitioned to permanent CFO, effective today. Ms. Tinnelly has served as Vice President and Corporate Controller of Reed's since July 2018. Throughout her tenure at the Company, she has stepped into the role of Interim CFO on two separate occasions, most recently in March 2023. She is a Certified Public Accountant with more than 30 years of finance and accounting experience in global public and private companies. Ms. Tinnell

    10/26/23 4:05:00 PM ET
    $REED

    Reed's Appoints Shufen Deng to its Board of Directors

    NORWALK, Conn., July 13, 2023 (GLOBE NEWSWIRE) -- Reed's, Inc. (OTCQX:REED) ("Reed's" or the "Company"), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, has appointed Shufen Deng to its board of directors (the "Board") effective July 7, 2023. Ms. Deng replaces Leon Zaltzman on the Board, who has transitioned to a Board Observer position. Ms. Deng brings more than 30 years of legal and capital markets experience to Reed's and is the sole shareholder and director of D&D Source of Life Holding Ltd. ("D&D"), the Company's largest shareholder. As announced on May 31, 2023, Reed's closed a series of financing transactions, led by a $3.0 million strategic invest

    7/13/23 8:00:43 AM ET
    $REED

    $REED
    SEC Filings

    View All

    Reed's Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - REED'S, INC. (0001140215) (Filer)

    12/29/25 4:55:05 PM ET
    $REED

    SEC Form 8-K filed by Reed's Inc.

    8-K - REED'S, INC. (0001140215) (Filer)

    12/8/25 4:15:48 PM ET
    $REED

    SEC Form 424B4 filed by Reeds Inc.

    424B4 - REED'S, INC. (0001140215) (Filer)

    12/5/25 5:25:43 PM ET
    $REED

    $REED
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Reed's, Inc. Announces Appointment of Neal Cohane as Chief Operating Officer

    NORWALK, Conn., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Reed's, Inc. (NYSE:REED) ("Reed's" or the "Company"), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, today announced the appointment of Neal Cohane as Chief Operating Officer, effective January 5, 2026. Mr. Cohane brings decades of leadership experience across the beverage industry and a proven track record of building high-performing commercial organizations, scaling national distribution, and driving sustainable growth for consumer brands. Most recently, he served as Chief Sales Officer at Eastroc Beverages and previously founded Rootstock Brands, Inc., where he advised beverage companies on go-to-mar

    12/29/25 4:30:00 PM ET
    $REED

    Reed's, Inc. Announces Closing of $10 Million Public Offering and Uplisting to NYSE American Stock Exchange

    NORWALK, Conn., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Reed's, Inc. (NYSE:REED) ("Reed's" or the "Company"), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, today announced the closing of its previously announced underwritten public offering of 2,500,000 shares of its common stock and warrants to purchase 2,500,000 shares of common stock (collectively, the "Securities"). Each share of common stock and accompanying warrant to purchase one share of common stock were sold together at a combined public offering price of $4.00. The warrants have an exercise price of $4.50 per share, are exercisable immediately and will expire five years from the issuance date. In ad

    12/8/25 4:05:00 PM ET
    $REED

    Reed's, Inc. Announces Pricing of $10 Million Public Offering and Uplisting to NYSE American Stock Exchange

    NORWALK, Conn., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Reed's, Inc. (NYSE:REED) ("Reed's" or the "Company"), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, today announced the pricing of an underwritten public offering of 2,500,000 shares of its common stock and warrants to purchase 2,500,000 shares of common stock (collectively, the "Securities"). Each share of common stock and accompanying warrant to purchase one share of common stock are being sold together at a combined public offering price of $4.00. The warrants will have an exercise price of $4.50 per share, will be exercisable immediately and will expire five years from the issuance date. In addition,

    12/5/25 8:00:00 AM ET
    $REED

    $REED
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Era Regenerative Medicine Ltd bought 1,075,269 shares (SEC Form 4)

    4 - REED'S, INC. (0001140215) (Issuer)

    6/11/25 4:36:43 PM ET
    $REED

    Large owner Union Square Park Capital Management, Llc bought $796,808 worth of shares (531,205 units at $1.50) (SEC Form 4)

    4 - REED'S, INC. (0001140215) (Issuer)

    9/24/24 1:58:51 PM ET
    $REED

    Director Deng Shufen bought $7,903,194 worth of shares (4,429,337 units at $1.78) (SEC Form 4)

    4 - REED'S, INC. (0001140215) (Issuer)

    9/13/24 7:27:59 PM ET
    $REED

    $REED
    Financials

    Live finance-specific insights

    View All

    Reed's Reports Third Quarter 2025 Results

    NORWALK, Conn., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Reed's, Inc. (OTCQX:REED) ("Reed's" or the "Company"), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, is reporting financial results for the three and nine months ended September 30, 2025. Q3 2025 Financial Highlights (vs. Q3 2024): Net sales increased 4% to $7.0 million compared to $6.8 million.Gross profit remained flat at $1.2 million, with gross margin of 17% compared to 18%. Excluding inventory write-offs of $0.1 million, gross profit for the third quarter of 2025 was $1.3 million with gross margin of 19%.Delivery and handling costs decreased by 14% to $2.50 per case compared to $2.99 per case.Selli

    11/3/25 4:05:00 PM ET
    $REED

    Reed's Schedules Third Quarter 2025 Conference Call for November 4 at 8:30 a.m. ET

    NORWALK, Conn., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Reed's, Inc. (OTCQX:REED) ("Reed's" or the "Company"), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, will host a conference call on Tuesday, November 4, 2025, at 8:30 a.m. Eastern time to discuss its financial results for the three and nine months ended September 30, 2025. The Company's results will be reported in a press release prior to the call. Reed's management will host the conference call, followed by a question-and-answer period. Date: Tuesday, November 4, 2025Time: 8:30 a.m. Eastern timeToll-free dial-in number: (800) 717-1738International dial-in number: (646) 307-1865Conference ID: 71678Webca

    10/21/25 4:05:22 PM ET
    $REED

    Reed's Reports Second Quarter 2025 Results

    NORWALK, Conn., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Reed's, Inc. (OTCQX:REED) ("Reed's" or the "Company"), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, is reporting financial results for the three and six months ended June 30, 2025. Q2 2025 Financial Highlights (vs. Q2 2024): Net sales were $9.5 million compared to $11.9 million.Gross profit was $0.8 million compared to $3.8 million, with gross margin of 8% compared to 32%. Excluding inventory write-offs of $1.6 million, gross profit for the second quarter of 2025 was $2.4 million with gross margin of 25%.Delivery and handling costs were $2.83 per case compared to $2.18 per case.Selling, general and adm

    8/12/25 4:39:43 PM ET
    $REED

    $REED
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Reeds Inc.

    SC 13D/A - REED'S, INC. (0001140215) (Subject)

    12/6/24 4:30:32 PM ET
    $REED

    Amendment: SEC Form SC 13D/A filed by Reeds Inc.

    SC 13D/A - REED'S, INC. (0001140215) (Subject)

    12/4/24 6:11:30 AM ET
    $REED

    Amendment: SEC Form SC 13G/A filed by Reeds Inc.

    SC 13G/A - REED'S, INC. (0001140215) (Subject)

    11/21/24 4:06:20 PM ET
    $REED